<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Activated neutrophils cause tissue injury in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) </plain></SENT>
<SENT sid="1" pm="."><plain>Upon activation, they shed soluble Fc gamma IIIb receptors (sFc gamma RIIIb) </plain></SENT>
<SENT sid="2" pm="."><plain>The subsequent <z:mp ids='MP_0001845'>inflammatory response</z:mp> is modulated by several mediators, including neutrophil derived <z:chebi fb="0" ids="15647">leukotriene B4</z:chebi> (<z:chebi fb="0" ids="15647">LTB4</z:chebi>), <z:chebi fb="0" ids="28728">thromboxane B2</z:chebi> (<z:chebi fb="0" ids="28728">TXB2</z:chebi>), and <z:chebi fb="0" ids="15551">prostaglandin E2</z:chebi> (<z:chebi fb="0" ids="15551">PGE2</z:chebi>) </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was to determine the value of gut lavage sFc gamma RIII and eicosanoid measurements for the assessment of mucosal <z:mp ids='MP_0001845'>inflammation</z:mp> in IBD </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: A total of 18 patients with active IBD, 10 <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC), and eight <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (CD), and 12 control patients underwent whole gut lavage </plain></SENT>
<SENT sid="5" pm="."><plain>Disease activity, endoscopic appearance, and histopathology were graded </plain></SENT>
<SENT sid="6" pm="."><plain>Samples were processed for the determination of sFc gamma RIIIb, <z:chebi fb="0" ids="15647">LTB4</z:chebi>, <z:chebi fb="0" ids="15551">PGE2</z:chebi>, and <z:chebi fb="0" ids="28728">TXB2</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Soluble Fc gamma RIIIb concentrations were increased in both IBD groups </plain></SENT>
<SENT sid="8" pm="."><plain>Significant correlations were seen between sFc gamma RIIIb and <z:chebi fb="0" ids="15647">LTB4</z:chebi> values with histology scores </plain></SENT>
<SENT sid="9" pm="."><plain>Mean eicosanoid lavage fluid concentrations in control patients were 14.1 pg/ml for <z:chebi fb="0" ids="15647">LTB4</z:chebi>, 5.6 pg/ml for <z:chebi fb="0" ids="15551">PGE2</z:chebi>, and 397 pg/ml for <z:chebi fb="0" ids="28728">TXB2</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>Concentrations of <z:hpo ids='HP_0000001'>all</z:hpo> <z:chebi fb="0" ids="23899">eicosanoids</z:chebi> in IBD patients were significantly increased: <z:chebi fb="0" ids="15647">LTB4</z:chebi> in UC: mean 73.2 pg/ml, in CD: 96.4 pg/ml (both p &lt; 0.01 v controls) </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="0" ids="15551">PGE2</z:chebi> in UC: 20.2 pg/ml, in CD: 43.4 pg/ml (p &lt; 0.01) </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="0" ids="28728">TXB2</z:chebi> in UC: 719.3 pg/ml, in CD: 180.6 pg/ml (both p &lt; 0.05) </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Whole gut lavage fluid analysis is an effective method to study mucosal eicosanoid production </plain></SENT>
<SENT sid="14" pm="."><plain>Soluble Fc gamma RIIIb concentrations in gut lavage fluid closely correlate with histological signs of mucosal <z:mp ids='MP_0001845'>inflammation</z:mp> and with lavage <z:chebi fb="0" ids="15647">LTB4</z:chebi> concentration </plain></SENT>
<SENT sid="15" pm="."><plain>These data suggest that lavage Fc gamma RIIIb assessment may be used as a simple assay to estimate mucosal neutrophil infiltration in IBD </plain></SENT>
</text></document>